HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Edith Hochhauser Bernardo Vidne Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hochhauser, E. Articles by Vidne, B. Search for Related Content PubMed PubMed Citation Articles by Hochhauser, E. Articles by Vidne, B.

Ann Thorac Surg 1988;46:208-213
© 1988 The Society of Thoracic Surgeons

---

Articles

Effect of Experimental Cardioplegia Methods on Normal and Hypertrophied Rat Hearts

From the Department of Thoracic and Cardiovascular Surgery, Tel Aviv Medical Center, Ichilov Hospital, Tel Aviv, Israel

Accepted for publication February 4, 1988.

^* Address reprint requests to Dr. Vidne, Ichilov Hospital, 6 Weizman St, Tel Aviv 64239, Israel.

The purpose of this study was to evaluate whether the addition of verapamil hydrochloride to oxygenated glucose-rich cardioplegic solution would improve myocardial preservation. The Langendorff preparation of the isolated rat heart was used. Groups of normal (WKY) and hypertrophied (SHR) hearts were treated by five different cardioplegic methods and subjected to 90 or 30 minutes of ischemia at 28° to 29°C and reperfusion at 37°C. The following cardioplegic solutions were used: Group A, cold (16°C) Krebs-Henseleit (KH) glucose free only; Group B, KH with KCL (30 mEq/L) (16°C); Group C, same as B with verapamil (10 µM); Group D, perfusion with oxygenated KH solution containing KCL (30 mEq/L) for 15 minutes prior to ischemia; and Group E, same as D with verapamil (10 µM). Recovery of contraction amplitude, ischemic contracture, coronary perfusate volume, the amount of creatine kinase in the coronary perfusate, heart rate, time of revival, O₂ consumption, and ischemic contracture were measured. After 30 minutes of ischemia, we did not find any significant difference among the combinations tested with respect to contraction amplitude recovery. The hearts recovered fully. After 90 minutes of ischemia, we found that the best-protected groups in the normal hearts were Groups D and E. In the hypertrophied hearts, the addition of verapamil to the enhancement solution was harmful. The use of enhancement solution without verapamil prior to ischemia provided the best myocardial protection in the hypertrophied hearts.

This article has been cited by other articles:

				E. Hochhauser, D. Leshem, O. Kaminski, Y. Cheporko, B. A. Vidne, and A. Shainberg The protective effect of prior ischemia reperfusion adenosine A1 or A3 receptor activation in the normal and hypertrophied heart Interact CardioVasc Thorac Surg, June 1, 2007; 6(3): 363 - 368. [Abstract] [Full Text] [PDF]

				P. Menasche, F. Tronc, A. Nguyen, L. Veyssie, M. Demirag, J. Lariviere, O. Le Dref, A. H. Piwnica, and G. Bloch Retrograde warm blood cardioplegia preserves hypertrophied myocardium: A clinical study Ann. Thorac. Surg., June 1, 1994; 57(6): 1429 - 1435. [Abstract] [PDF]